Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells

被引:57
作者
Li, Zhengyu [1 ]
Liu, Yi [1 ]
Zhao, Xia [1 ]
Pan, Xiaoling [1 ]
Yin, Rutie [1 ]
Huang, Canhua [2 ]
Chen, Lijuan [2 ]
Wei, Yuquan [2 ]
机构
[1] Sichuan Univ, Dept Obstet & Gynecol, W China Hosp 2, Chengdu 610041, Peoples R China
[2] Sichuan Univ, State Key Lab Biotherapy Human Dis, W China Hosp, Chengdu 610041, Peoples R China
关键词
honokiol; ovarian tumor; apoptosis; angiogenesis;
D O I
10.1016/j.ejogrb.2008.02.023
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To observe the anti-tumor activities of honokiol on human ovarian tumor in vitro and in vivo. Study design: Cells were treated with honokiol, and the effects on proliferation and apoptosis were examined by MTT, DNA ladder, Hoechst staining, and flow cytometry assays. Expression of Bcl-2 members and caspase-3 were assessed. Measurements of tumor volume and microvessel densities (MVDs) were performed. Results: Honokiol significantly inhibited proliferation and induced apoptosis, with alteration of Bcl-2 members and caspase-3. Administration of honokiol to tumor-bearing animals decreased MVD and resulted in inhibition of tumor growth. Conclusions: Honokiol could induce apoptosis and inhibit angiogenesis in vitro and in vivo, suggesting a novel and attractive therapeutic candidate for ovarian tumor treatment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:95 / 102
页数:8
相关论文
共 31 条
[11]  
Hibasami H, 1998, INT J MOL MED, V2, P671
[12]   THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA [J].
HOSKINS, WJ ;
MCGUIRE, WP ;
BRADY, MF ;
HOMESLEY, HD ;
CREASMAN, WT ;
BERMAN, M ;
BALL, H ;
BEREK, JS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 170 (04) :974-980
[13]   Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation [J].
Hu, YM ;
Benedict, MA ;
Wu, DY ;
Inohara, N ;
Núñez, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4386-4391
[14]   Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis [J].
Ishitsuka, K ;
Hideshima, T ;
Hamasaki, M ;
Raje, N ;
Kumar, S ;
Hideshima, H ;
Shiraishi, N ;
Yasui, H ;
Roccaro, AM ;
Richardson, P ;
Podar, K ;
Le Gouill, S ;
Chauhan, D ;
Tamura, K ;
Arbiser, J ;
Anderson, KC .
BLOOD, 2005, 106 (05) :1794-1800
[15]   Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice [J].
Kuribara, H ;
Stavinoha, WB ;
Maruyama, Y .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (07) :819-826
[16]   The inhibitory effects of aqueous extract of magnolia officinalis on human mesangial cell proliferation by regulation of platelet-derived growth factor-BB and transforming growth factor-β1 expression [J].
Lee, BC ;
Doo, HK ;
Lee, HJ ;
Jin, SY ;
Jung, JH ;
Hong, SJ ;
Lee, SH ;
Kim, SD ;
Park, JK ;
Leem, KF ;
Ahn, SY .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (01) :81-85
[17]   Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore [J].
Li, Ling ;
Han, Weidong ;
Gu, Ying ;
Qiu, Shuang ;
Lu, Qinghua ;
Jin, Jie ;
Luo, Jianhong ;
Hu, Xun .
CANCER RESEARCH, 2007, 67 (10) :4894-4903
[18]   Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells [J].
Shigemura, Katsumi ;
Arbiser, Jack L. ;
Sun, Shi-Yong ;
Zayzafoon, Majd ;
Johnstone, Peter A. S. ;
Fujisawa, Masato ;
Gotoh, Akinobu ;
Weksler, Babette ;
Zhau, Haiyen E. ;
Chung, Leland W. K. .
CANCER, 2007, 109 (07) :1279-1289
[19]  
Singh Sarvjeet, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P259, DOI 10.2174/187152006776930918
[20]   Rac regulates vascular endothelial growth factor stimulated motility [J].
Soga, N ;
Connolly, JO ;
Chellaiah, M ;
Kawamura, J ;
Hruska, KA .
CELL COMMUNICATION AND ADHESION, 2001, 8 (01) :1-13